Search research articles
Contact Us
Filters
Showing results (181-190 of 242) with videos related to
Page
of 25
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Michael Benatar, Joanne Wuu, Peter M Andersen, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 29, 2022
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Michael Benatar, Joanne Wuu, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 6, 2025
ALSUntangled #81: Pyridostigmine (mestinon<sup>®</sup>)
Nadia Mansoor, Terry Heiman-Patterson, Eva L Feldman, et al.
Neurobiology of Aging
|
October 31, 2012
Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians
Martin A Kohli, Krista John-Williams, Ruchita Rajbhandary, et al.
Muscle & Nerve
|
June 29, 2026
At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial
Eric A Macklin, James D Berry, Brittney A Harkey, et al.
The Lancet. Neurology
|
February 19, 2013
Controversies and priorities in amyotrophic lateral sclerosis
Martin R Turner, Orla Hardiman, Michael Benatar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 15, 2022
ALSUntangled #67: rituximab
Xiaoyan Li, Carmel Armon, Paul Barkhaus, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 5, 2025
ALSUntangled #80: ISRIB (Integrated stress response InhiBitor)
Javier Mascias Cadavid, Anna Mena Bravo, Paul Barkhaus, et al.
Neurology
|
August 13, 2017
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review
Michael K Hehir, Lisa D Hobson-Webb, Michael Benatar, et al.
Genome Research
|
August 24, 2019
Pediatric Cancer Variant Pathogenicity Information Exchange (PeCanPIE): a cloud-based platform for curating and classifying germline variants
Michael N Edmonson, Aman N Patel, Dale J Hedges, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 242) with videos related to
Sort By:
Page
of 25
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
May 18, 2022
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Michael Benatar, Joanne Wuu, Peter M Andersen, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 29, 2022
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Michael Benatar, Joanne Wuu, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
November 6, 2025
ALSUntangled #81: Pyridostigmine (mestinon<sup>®</sup>)
Nadia Mansoor, Terry Heiman-Patterson, Eva L Feldman, et al.
Neurobiology of Aging
|
October 31, 2012
Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians
Martin A Kohli, Krista John-Williams, Ruchita Rajbhandary, et al.
Muscle & Nerve
|
June 29, 2026
At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial
Eric A Macklin, James D Berry, Brittney A Harkey, et al.
The Lancet. Neurology
|
February 19, 2013
Controversies and priorities in amyotrophic lateral sclerosis
Martin R Turner, Orla Hardiman, Michael Benatar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 15, 2022
ALSUntangled #67: rituximab
Xiaoyan Li, Carmel Armon, Paul Barkhaus, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
August 5, 2025
ALSUntangled #80: ISRIB (Integrated stress response InhiBitor)
Javier Mascias Cadavid, Anna Mena Bravo, Paul Barkhaus, et al.
Neurology
|
August 13, 2017
Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review
Michael K Hehir, Lisa D Hobson-Webb, Michael Benatar, et al.
Genome Research
|
August 24, 2019
Pediatric Cancer Variant Pathogenicity Information Exchange (PeCanPIE): a cloud-based platform for curating and classifying germline variants
Michael N Edmonson, Aman N Patel, Dale J Hedges, et al.
Page
of 25